Repligen Corporation RGEN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 805.61M | 785.10M | 763.34M | 738.26M | 707.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 805.61M | 785.10M | 763.34M | 738.26M | 707.89M |
| Cost of Revenue | 372.47M | 362.43M | 357.71M | 349.54M | 342.70M |
| Gross Profit | 433.14M | 422.67M | 405.63M | 388.71M | 365.19M |
| SG&A Expenses | 311.11M | 301.18M | 295.47M | 289.64M | 275.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 740.01M | 719.78M | 708.91M | 692.56M | 670.23M |
| Operating Income | 65.60M | 65.32M | 54.43M | 45.70M | 37.66M |
| Income Before Tax | 8.23M | 52.15M | 56.21M | 62.38M | 4.66M |
| Income Tax Expenses | 20.03M | 10.61M | 4.82M | 13.49M | 2.92M |
| Earnings from Continuing Operations | -11.80 | 41.54 | 51.40 | 48.89 | 1.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.80M | 41.54M | 51.40M | 48.89M | 1.74M |
| EBIT | 65.60M | 65.32M | 54.43M | 45.70M | 37.66M |
| EBITDA | 143.50M | 144.10M | 134.24M | 124.44M | 114.82M |
| EPS Basic | -0.21 | 0.74 | 0.91 | 0.87 | 0.03 |
| Normalized Basic EPS | 0.77 | 0.74 | 0.66 | 0.59 | 0.46 |
| EPS Diluted | -0.21 | 0.73 | 0.90 | 0.85 | 0.01 |
| Normalized Diluted EPS | 0.76 | 0.73 | 0.66 | 0.58 | 0.46 |
| Average Basic Shares Outstanding | 225.64M | 225.35M | 225.16M | 224.93M | 224.68M |
| Average Diluted Shares Outstanding | 226.52M | 226.50M | 226.37M | 226.26M | 225.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |